These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25798811)

  • 1. Clinical, Histologic, and Molecular Analysis of Differences Between Erythematotelangiectatic Rosacea and Telangiectatic Photoaging.
    Helfrich YR; Maier LE; Cui Y; Fisher GJ; Chubb H; Fligiel S; Sachs D; Varani J; Voorhees J
    JAMA Dermatol; 2015 Aug; 151(8):825-36. PubMed ID: 25798811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of photo-induced collagen degeneration and the development of telangiectasias in rosacea.
    Thompson KG; Rainer BM; Leung S; Qi J; Kang S; Chien AL
    J Anat; 2021 Jun; 238(6):1355-1358. PubMed ID: 33432575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythematotelangiectatic Rosacea and Telangiectatic Photoaging: Same, Separate, and/or Sequential?
    Wilkin JK
    JAMA Dermatol; 2015 Aug; 151(8):821-3. PubMed ID: 25798736
    [No Abstract]   [Full Text] [Related]  

  • 4. Videocapillaroscopic alterations in erythematotelangiectatic rosacea.
    Rosina P; Zamperetti MR; Giovannini A; Chieregato C; Girolomoni G
    J Am Acad Dermatol; 2006 Jan; 54(1):100-4. PubMed ID: 16384763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series.
    Kapicioglu Y; Sarac G; Cenk H
    Lasers Med Sci; 2019 Feb; 34(1):93-98. PubMed ID: 30097757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating and Optimizing the Diagnosis of Erythematotelangiectatic Rosacea.
    Saleem MD; Wilkin JK
    Dermatol Clin; 2018 Apr; 36(2):127-134. PubMed ID: 29499796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosacea or photodamaged skin? Use of brimonidine gel in differentiating erythema in the two conditions.
    Oon HH; Lim ZV
    Australas J Dermatol; 2017 Feb; 58(1):63-64. PubMed ID: 26763464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigastric rosacea.
    Wilkin JK
    Arch Dermatol; 1980 May; 116(5):584. PubMed ID: 6445709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity.
    Harper J; Del Rosso JQ; Ferrusi IL
    J Drugs Dermatol; 2018 Feb; 17(2):150-158. PubMed ID: 29462222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of subjective recognition and computer-aided image analysis of facial erythematous skin diseases: a cornerstone of automated diagnosis.
    Choi JW; Kim BR; Lee HS; Youn SW
    Br J Dermatol; 2014 Aug; 171(2):252-8. PubMed ID: 24354615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic and hypertrophic photoaging: Clinical, histologic, and molecular features of 2 distinct phenotypes of photoaged skin.
    Sachs DL; Varani J; Chubb H; Fligiel SEG; Cui Y; Calderone K; Helfrich Y; Fisher GJ; Voorhees JJ
    J Am Acad Dermatol; 2019 Aug; 81(2):480-488. PubMed ID: 30954583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of intense pulsed light for different erythema associated with rosacea.
    Liu J; Liu J; Ren Y; Li B; Lu S
    J Cosmet Laser Ther; 2014 Dec; 16(6):324-7. PubMed ID: 25151911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Study of Factors Affecting Efficacy of Therapy with Dye Pulsed Light for Erythematotelangiectatic Rosacea.
    Zhao L; You C; Chen H; Wang J; Cao J; Qi M; Hou S; Zheng X; Shao L; Liu Q
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1273-1283. PubMed ID: 32865718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosacea in acne vulgaris patients: Subtype distribution and triggers assessment-A cross-sectional study.
    Chen H; Lai W; Zheng Y
    J Cosmet Dermatol; 2021 Jun; 20(6):1889-1896. PubMed ID: 33025720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes.
    Tan J; Blume-Peytavi U; Ortonne JP; Wilhelm K; Marticou L; Baltas E; Rivier M; Petit L; Martel P
    Br J Dermatol; 2013 Sep; 169(3):555-62. PubMed ID: 23600367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: comparison of clinical efficacy and effect on cutaneous substance (P) expression.
    Salem SA; Abdel Fattah NS; Tantawy SM; El-Badawy NM; Abd El-Aziz YA
    J Cosmet Dermatol; 2013 Sep; 12(3):187-94. PubMed ID: 23992160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and histopathologic study of granulomatous rosacea.
    Helm KF; Menz J; Gibson LE; Dicken CH
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1038-43. PubMed ID: 1839796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological Analysis of 226 Patients With Rosacea According to Rosacea Subtype and Severity.
    Lee WJ; Jung JM; Lee YJ; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    Am J Dermatopathol; 2016 May; 38(5):347-52. PubMed ID: 26460622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component.
    Micali G; Dall'Oglio F; Verzì AE; Luppino I; Bhatt K; Lacarrubba F
    Lasers Med Sci; 2018 Aug; 33(6):1397-1400. PubMed ID: 28889348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.